Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111328332A details a novel synthetic route for cholic and deoxycholic acid from plant-derived DHEA, ensuring high purity and eliminating animal-derived impurities for reliable supply chains.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN1032361C details novel imidazopyridazine derivatives with anti-asthmatic activity. Learn about scalable synthesis routes and cost-effective manufacturing strategies for high-purity intermediates.
Novel zirconium-catalyzed process for high-purity PPI intermediates. Reduces costs and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN101270091A details a clean hydrazine reduction and zinc chloride separation method for high-purity albendazole intermediates.
Advanced patent-based synthesis of cinacalcet intermediate offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN113336791A details a novel ZSM-5 supported catalyst method for Fosfomycin Calcium, offering higher yields and reduced heavy metal residues for antibiotic manufacturing.
Novel MOF-catalyzed route eliminates genotoxic 2-MBT impurities effectively. High-purity ceftiofur sodium manufacturing for veterinary pharmaceutical supply chains ensures safety and compliance.
Patent CN109761810B details a solvent-free ball milling method for oxidative Heck coupling, offering high yields and rapid synthesis for pharmaceutical intermediates.
Patent CN109761810B reveals a solvent-free oxidative Heck reaction using mechanical grinding. This breakthrough enables high-yield synthesis of inactive olefin aryl compounds with significant cost and time reductions.
Novel route for Midazolam via M2 intermediate avoids genotoxic impurities. High purity, scalable process for pharmaceutical manufacturing.
Patent CN1777572A reveals a robust ketone-based route for alkoxyphenols, offering superior stability and yield for reliable pharmaceutical intermediates supplier networks.
Novel patent CN103965190A offers high-purity pharmaceutical intermediates via mild conditions. Reduces cost and ensures supply chain reliability for global buyers.
Patent CN100341842C details a green oxidation route for formylcyclopropanecarboxylate esters, offering cost reduction in pyrethroid manufacturing and enhanced supply chain reliability.
Patent CN104447434B details a green catalytic oxidation method for p-carboxybenzenesulfonamide. Offers high purity, reduced waste, and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN1207287C reveals a streamlined synthesis for Candesartan Cilexetil intermediates, offering significant cost reduction in pharmaceutical manufacturing through simplified late-stage coupling.
Patent CN111087338B reveals a copper-catalyzed route for sulfonamide-substituted pyrrolidones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN1186310C details a tungsten-catalyzed oxidation route for agrochemical intermediates, offering safer processing and scalable production capabilities.
Patent CN113755867A details a green electrochemical route for 2-carboxy-5-nitrobenzenesulfonic acid, ensuring high purity and reduced waste for agrochemical intermediates.
Patent CN102264715B reveals a scalable cinchonidine salt resolution process for HCV inhibitors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.